Jane Street
IMVT icon

Jane Street’s Immunovant IMVT Stock Holding History

Jane Street’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$907K Buy
36,500
+16,600
+83% +$430K ﹤0.01% 6722
2025
Q4 		$506K Sell
19,900
-51,100
-72% -$1.14M ﹤0.01% 7667
2025
Q3 		$1.14M Buy
71,000
+38,400
+118% +$622K ﹤0.01% 6020
2025
Q2 		$522K Sell
32,600
-145,000
-82% -$2.19M ﹤0.01% 6842
2025
Q1 		$3.04M Buy
177,600
+51,800
+41% +$1.08M ﹤0.01% 3699
2024
Q4 		$3.12M Sell
125,800
-54,100
-30% -$1.53M ﹤0.01% 3377
2024
Q3 		$5.13M Buy
179,900
+61,200
+52% +$1.8M ﹤0.01% 2824
2024
Q2 		$3.13M Buy
118,700
+54,900
+86% +$1.56M ﹤0.01% 3743
2024
Q1 		$2.06M Sell
63,800
-58,900
-48% -$2.15M ﹤0.01% 4069
2023
Q4 		$5.17M Sell
122,700
-263,200
-68% -$9.69M ﹤0.01% 2798
2023
Q3 		$14.8M Buy
+385,900
New +$8.72M ﹤0.01% 1372
2022
Q1 		– Sell
-12,500
Closed -$107K – 10645
2021
Q4 		$107K Sell
12,500
-69,900
-85% -$577K ﹤0.01% 9213
2021
Q3 		$716K Sell
82,400
-6,700
-8% -$60.4K ﹤0.01% 6597
2021
Q2 		$942K Buy
+89,100
New +$1.24M ﹤0.01% 5967

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Jane Street's IMVT Position: Q1 2026 in Review

Jane Street opened a new position in Immunovant (IMVT) in Q1 2026: 84,312 shares worth $2.09M. The stake represents ﹤0.01% of the portfolio and ranks #4991 among its holdings. This is a return to the name: Jane Street previously reported a position in IMVT as recently as Q3 2025.

Jane Street first reported a position in IMVT in Q1 2020 and has held it in 21 quarters since. The position peaked at $25.9M in Q4 2023. 215 funds tracked by Wall St. Rank hold IMVT as of Q1 2026.

  • Jane Street held 84,312 shares of Immunovant worth $2.09M as of Q1 2026.
  • Immunovant was a new Jane Street position in Q1 2026.
  • Immunovant made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #4991 holding.
  • Jane Street first reported a position in Immunovant in Q1 2020 and has held it in 21 quarters since.
  • Jane Street's Immunovant position peaked at $25.9M in Q4 2023.
  • 215 funds tracked by Wall St. Rank held Immunovant as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.